Response of brain metastases from breast cancer to megestrol acetate: A case report
Open Access
- 1 January 1995
- journal article
- case report
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 24 (3), 299-301
- https://doi.org/10.1007/bf01052847
Abstract
A 56 year old women was treated with megestrol acetate (Megace) 40 mg p.o. q.i.d. for her cerebellar metastasis of primary adenocarcinoma of the breast. She had previously undergone two surgical resections of her brain metastasis, and a course of radiotherapy. After failing to tolerate tamoxifen therapy, she received Megace, with marked improvement in her cerebellar tumor on CT scans. Despite good control of her brain tumor with Megace, she developed progressive neurological symptoms thought to be due to meningeal carcinomatosis, and died two years after initiating Megace therapy. We conclude that Megace could potentially be beneficial in some patients with brain metastases from adenocarcinoma of the breast.Keywords
This publication has 12 references indexed in Scilit:
- A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumorsJournal of Neuro-Oncology, 1994
- Progestins in Breast Cancer Treatment: A ReveiwActa Oncologica, 1992
- Longterm remission of multiple brain metastases with tamoxifenJournal of Neuro-Oncology, 1991
- Complete Remission of a Brain Metastasis to Third-Line Hormonal Treatment with Megestrol AcetateAmerican Journal of Clinical Oncology, 1990
- Chemotherapy induces regression of brain metastases in breast carcinomaCancer, 1986
- Brain metastases and testicular tumors: need for aggressive therapy.Journal of Clinical Oncology, 1984
- Tamoxifen-induced regression of cerebral metastases in breast carcinoma.1981
- Radation therapy for brain metastasesAnnals of Neurology, 1980
- Chemotherapy of Brain TumorsArchives of Neurology, 1977
- Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumorsEuropean Journal of Cancer (1965), 1975